Changing Epidemiology, Outcomes, and Testing for HPV‐Associated Sinonasal Squamous Cell Carcinoma: Should Routine HPV Testing Be Encouraged?
Incidence of HPV-associated sinonasal squamous cell carcinoma (SNSCC) is rising and the majority of SNCCs are now HPV-associated (61%). Rate of pathologic HPV testing of sinonasal tumors is declining, from 61.1% (2011-2013) to 33.3% (2021-2024). Given improved survival with HPV-associated SNSCCs and emergence of novel surveillance methods, routine pathologic HPV testing of SNSCC should be considered.
Authors
- Nikita Chapurin (ORCID: https://orcid.org/0000-0002-3744-0451)
- E. Im
- Avraham Adelman (ORCID: https://orcid.org/0000-0002-0577-1635)
- Jeb M. Justice (ORCID: https://orcid.org/0000-0003-4729-028X)
- Brian C. Lobo (ORCID: https://orcid.org/0000-0003-1533-1665)
- Young Lee (ORCID: https://orcid.org/0000-0001-5543-4701)
Institutions
- University of Florida (US)
Publication Details
- Journal
- International Forum of Allergy & Rhinology
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1002/alr.23611
- Primary Topic
- Head and Neck Surgical Oncology
- Type
- article
- Field-Weighted Citation Impact
- 0.00